semaglutideresmetiromQF70hepatocellular carcinomacirrhosisFDAUS food and drug administrationmetabolic dysfunction-associated steatotic liver disease (MASLD)
…d-stage liver diseases. However, only two drugs, resmetirom and semaglutide, have been approved by the US food and drug administration (FDA…